Repligen Corp Leadership

President and CEO of Repligen; joined October 2023 as President and Chief Commercial Officer; former CEO of Ascensus Specialties and Bioprocess President at Cytiva.

Chair of the Repligen Board since March 2026; senior operating executive at The Carlyle Group; former Chairman, President and CEO of Millipore.

President of Knowledgeable Decisions, LLC; former Lead Independent Director of Repligen; former SVP at Bayer and Wyeth.

Senior Advisor at Warburg Pincus since 2020; former President and CEO of bioTheranostics; former President, Global Commercial Operations at Life Technologies.

President and CEO of OraSure Technologies since 2022; former SVP at Quest Diagnostics; two decades at GE Healthcare.

Chief Technology Officer at Ring Therapeutics and Operating Partner at Flagship Pioneering; former CTO at Codiak BioSciences.

Executive Vice President and Chief Technical Operations Officer at Parabilis Medicines (formerly FogPharma); 27 years at Biogen.

Retired CFO and Executive Vice President of Hologic, Inc.; 26 years with Hologic.

Former Vice President, Strategy and Innovation at Thermo Fisher Scientific; over 30 years in life sciences growth strategy.

CFO of Repligen since September 2023; former EVP and CFO of Integer Holdings; ~20 years at General Electric.

COO of Repligen since January 2022; joined March 2020 as SVP, Global Operations and IT; ten years at Thermo Fisher.

SVP, R&D at Repligen since October 2016; former VP at Pall Corporation's Life Sciences single-use business unit.

SVP and Chief Product Officer of Repligen since December 2025; joined May 2024 as SVP, Filtration and Chromatography; former VP/GM at Thermo Fisher.

Chief Accounting Officer and principal accounting officer of Repligen, effective September 1, 2025; former Chief Accounting Officer at Azenta.

Departing Executive Chair of the Board; former Chief Executive Officer of Repligen; retired from the Board effective March 13, 2026.